577 related articles for article (PubMed ID: 16110022)
21. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.
Wright CM; Dent OF; Barker M; Newland RC; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
Br J Surg; 2000 Sep; 87(9):1197-202. PubMed ID: 10971428
[TBL] [Abstract][Full Text] [Related]
22. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
25. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
[TBL] [Abstract][Full Text] [Related]
26. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
28. p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy.
Tang R; Wang JY; Fan CW; Tsao KC; Chen HH; Wu CM; Chen JS; Changchien CR; Hsieh LL
Cancer Lett; 2004 Jul; 210(1):101-9. PubMed ID: 15172127
[TBL] [Abstract][Full Text] [Related]
29. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
30. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.
Liang JT; Huang KC; Cheng AL; Jeng YM; Wu MS; Wang SM
Br J Surg; 2003 Feb; 90(2):205-14. PubMed ID: 12555297
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers.
Beghelli S; de Manzoni G; Barbi S; Tomezzoli A; Roviello F; Di Gregorio C; Vindigni C; Bortesi L; Parisi A; Saragoni L; Scarpa A; Moore PS
Surgery; 2006 Mar; 139(3):347-56. PubMed ID: 16546499
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
34. Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.
de Weger VA; Turksma AW; Voorham QJ; Euler Z; Bril H; van den Eertwegh AJ; Bloemena E; Pinedo HM; Vermorken JB; van Tinteren H; Meijer GA; Hooijberg E
Clin Cancer Res; 2012 Feb; 18(3):882-9. PubMed ID: 22156611
[TBL] [Abstract][Full Text] [Related]
35. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
[TBL] [Abstract][Full Text] [Related]
36. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC
Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of mitochondrial mutations in colorectal cancer.
Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon.
Pricolo VE; Finkelstein SD; Wu TT; Keller G; Bakker A; Swalsky PA; Bland KI
Am J Surg; 1996 Jan; 171(1):41-6. PubMed ID: 8554149
[TBL] [Abstract][Full Text] [Related]
39. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer.
Chang EY; Dorsey PB; Frankhouse J; Lee RG; Walts D; Johnson W; Anadiotis G; Johnson N
Arch Surg; 2009 Jun; 144(6):511-5. PubMed ID: 19528382
[TBL] [Abstract][Full Text] [Related]
40. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
Oncology; 2000; 58(1):52-9. PubMed ID: 10644941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
